Care of the lung cancer patient-screening, diagnosis, and treatment-has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management.- Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more- Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies- Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and PET/CT and CT imaging for diagnosis and treatment planning- Features “Top 5 Clinical Pearls” at the beginning of each chapter- Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Lung Cancer Screening and Prevention 2. Lung Cancer: Diagnostic Techniques 3. Histology and Molecular Testing 4. Surgical Considerations in Lung Cancer Treatment 5. Surgically Resectable Disease 6. Oligometastatic Disease 7. Locally Advanced Non-Small Cell Lung Cancer 8. First-Line Therapy 9. Second-Line Therapy in Advanced Non-Small Cell Lung Cancer 10. Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach 11. Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer 12. Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS 13. Immunotherapy 14. Small Cell Lung Cancer
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net